Acute Coronary Syndrome News and Research RSS Feed - Acute Coronary Syndrome News and Research

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies. [More]
New study reports both young men and women with ACS have good one-year prognosis

New study reports both young men and women with ACS have good one-year prognosis

It has become commonly accepted that women do worse than men following a heart attack or other coronary event. [More]
Benefits of cardioprotective drugs may extend beyond preventing acute coronary syndromes

Benefits of cardioprotective drugs may extend beyond preventing acute coronary syndromes

Medications prescribed to prevent heart attacks such as statins and aspirin are also associated with reduced heart attack severity, according to research published in PLOS ONE. [More]
New Focused Update to CCS atrial fibrillation guidelines released

New Focused Update to CCS atrial fibrillation guidelines released

The Canadian Journal of Cardiology has just released the 2016 Focused Update to the Canadian Cardiovascular Society's atrial fibrillation (AF) guidelines. [More]
OPTICARE study shows year-long CR program makes heart patients happier, healthier and active

OPTICARE study shows year-long CR program makes heart patients happier, healthier and active

Enhanced cardiac rehabilitation (CR) programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard 3-month program in patients recovering from a heart attack. [More]
CPAP treatment offers no cardiovascular benefit in OSA patients with heart disease risk

CPAP treatment offers no cardiovascular benefit in OSA patients with heart disease risk

More than 3 years of nightly treatment with a continuous positive airway pressure (CPAP) machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea (OSA). [More]
Platelet function testing in elderly patients after heart attack shows no improved outcomes

Platelet function testing in elderly patients after heart attack shows no improved outcomes

Monitoring platelet function in order to individualize antiplatelet therapy did not improve outcomes for elderly patients after a heart attack compared to a standard, unmonitored approach, results of the ANTARCTIC trial show. [More]
Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows. [More]
HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin treatment alone in patients with acute coronary syndrome (ACS) and dyslipidemia, investigators reported here. [More]
Hidden dental root tip infections may increase risk of coronary artery disease

Hidden dental root tip infections may increase risk of coronary artery disease

According to a study carried out at the University of Helsinki, an infection of the root tip of a tooth increases the risk of coronary artery disease, even if the infection is symptomless. [More]
St. Luke’s Emergency and Transport Services recognized for excellence

St. Luke’s Emergency and Transport Services recognized for excellence

St. Luke’s Emergency and Transport Services has received the American Heart Association’s Mission: Lifeline® EMS Silver Award for implementing quality improvement measures for the treatment of patients who experience severe heart attacks. [More]
miRNAs may improve risk prediction in CAD

miRNAs may improve risk prediction in CAD

Single microRNAs derived from peripheral blood predict cardiovascular mortality in patients with coronary artery disease, German research shows. [More]
Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

The German Institute for Quality and Efficiency in Health Care assessed the added benefit of ticagrelor for patients with acute coronary syndrome already in 2011 in its very first dossier assessment, just after the Act on the Reform of the Market for Medicinal Products had come into force. [More]
Cardiac troponin test refines ACS rule-out process

Cardiac troponin test refines ACS rule-out process

Testing high-sensitivity cardiac troponin T levels in patients with acute coronary syndromes reduces their need for cardiac stress testing and speeds their discharge from the emergency department, report researchers. [More]
'Comprehensive' management approach needed for AF

'Comprehensive' management approach needed for AF

Death is a bigger risk than stroke among patients with atrial fibrillation, particularly during the first 4 months after diagnosis, research shows. [More]
Sleep-disordered breathing increases cardiovascular risk in ACS patients

Sleep-disordered breathing increases cardiovascular risk in ACS patients

Sleep-disordered breathing is an important risk factor for major adverse cardiocerebrovascular events among patients with acute coronary syndromes, Japanese research shows. [More]
Mortality risk high among diabetes patients with prior CV events

Mortality risk high among diabetes patients with prior CV events

Patients with Type 2 diabetes and acute coronary syndromes have a substantially increased risk of death in the 18 months after hospital admission for subsequent major nonfatal cardiovascular events, US researchers report. [More]
Age no barrier to vorapaxar use in ACS

Age no barrier to vorapaxar use in ACS

The protease-activated receptor 1 inhibitor vorapaxar offers the same benefits to older and younger patients with non-ST segment elevation acute coronary syndromes, shows further analysis of the TRACER trial. [More]
Diabetes-heart disease combination can increase death risk

Diabetes-heart disease combination can increase death risk

The combination of type 2 diabetes and coronary artery disease can be deadly. New research from a global study led by a physician from UConn Health has found that patients with Type 2 diabetes admitted into the hospital for congestive heart failure face a one in four chance of dying over the next 18 months. [More]
Rapid hand-held troponin blood test for heart attack diagnosis launched by Philips

Rapid hand-held troponin blood test for heart attack diagnosis launched by Philips

Chest pain patients presenting at the emergency department are set to benefit from a major development by Royal Philips. The company today announced that it has CE marked its cardiac troponin I (cTnI) blood test on the Minicare I-20 handheld device. Minicare cTnI delivers its lab comparable test results in less than 10 minutes near the patient, reducing the time for the physician to decide on treatment. [More]
Advertisement
Advertisement